๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO ยท Real-Time Price ยท USD
25.37
-1.14 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
25.42
+0.05 (0.20%)
After-hours: Nov 20, 2026, 7:30 PM EST

Alto Neuroscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.21
Revenue Growth
------
Gross Profit
-----0.21
Operating Income
-100.55-66.36-68.61-37.81-29.19-12.06
Net Income
-95.18-63.24-61.43-36.31-27.71-9.19
Earnings Per Share
-2.36-2.19-2.50-9.73-8.04-3.81
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
319.34176.48168.2382.5548.3425.71
Total Debt
18.0223.9616.949.999.87-
Net Cash (Debt)
301.32152.53151.2972.5638.4725.71
Net Cash Growth
173.20%0.82%108.49%88.61%49.67%-
Net Cash Per Share
7.485.296.1519.4511.1610.65

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-79.12-51.77-47.42-33.45-20.39-9.26
Capital Expenditures
-0.56-0.02-2.08-0.47-0.73-0.68
Free Cash Flow
-79.68-51.79-49.5-33.92-21.13-9.94
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------5740.95%
Pretax Margin
------4374.76%
Profit Margin
------4374.76%
FCF Margin
------4734.29%

Valuation

Selected indicators aren't available for this stock.